(Q33748132)

29 July 2017

1 reference

title

Blood-brain barrier properties of human immunodeficiency virus antiretrovirals (English)

1 reference

29 July 2017

1 reference

Yazdanian M

1

1 reference

29 July 2017

language of work or name

English

0 references

publication date

1 October 1999

1 reference

Journal of Pharmaceutical Sciences

29 July 2017

published in

1 reference

29 July 2017

volume

88

1 reference

29 July 2017

issue

10

1 reference

29 July 2017

page(s)

950-954

1 reference

Early viral brain invasion in iatrogenic human immunodeficiency virus infection

29 July 2017

cites work

1 reference

7 January 2021

High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients

1 reference

7 January 2021

Seminars in medicine of the Beth Israel Hospital, Boston. Dementia associated with the acquired immunodeficiency syndrome

1 reference

7 January 2021

Human immunodeficiency virus and the central nervous system

1 reference

7 January 2021

The role of the blood-brain barrier in HIV infection of the central nervous system

1 reference

7 January 2021

HIV infection of human brain capillary endothelial cells--implications for AIDS dementia

1 reference

7 January 2021

Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier

1 reference

7 January 2021

Absence of humorally mediated damage within the central nervous system of AIDS patients

1 reference

7 January 2021

Characterization of an in vitro blood-brain barrier model system for studying drug transport and metabolism

1 reference

7 January 2021

In vitro blood-brain barrier permeability of nevirapine compared to other HIV antiretroviral agents

1 reference

7 January 2021

Zidovudine treatment of the AIDS dementia complex: results of a placebo-controlled trial. AIDS Clinical Trials Group

1 reference

7 January 2021

Absorption and elimination kinetics of zidovudine in the cerebrospinal fluid in HIV-1-infected patients.

1 reference

7 January 2021

Methods for Quantifying the transport of drugs across brain barrier systems

1 reference

7 January 2021

The effect on human immunodeficiency virus type 1 RNA levels in cerebrospinal fluid after initiation of zidovudine or didanosine

1 reference

7 January 2021

AIDS dementia complex and didanosine

1 reference

7 January 2021

Long-term zidovudine reduces neurocognitive deficits in HIV-1 infection

1 reference

7 January 2021

Declining incidence of AIDS dementia complex after introduction of zidovudine treatment

1 reference

7 January 2021

Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine

1 reference

7 January 2021

Randomized, controlled phase I/II, trial of combination therapy with delavirdine (U-90152S) and conventional nucleosides in human immunodeficiency virus type 1-infected patients.

1 reference

7 January 2021

Indinavir in cerebrospinal fluid of HIV-1-infected patients

1 reference

7 January 2021

Failure to detect nelfinavir in the cerebrospinal fluid of HIV-1--infected patients with and without AIDS dementia complex.

1 reference

7 January 2021

The application of bovine brain microvessel endothelial-cell monolayers grown onto polycarbonate membranes in vitro to estimate the potential permeability of solutes through the blood-brain barrier.

1 reference

7 January 2021

Comparisons of P‐glycoprotein expression in isolated rat brain microvessels and in primary cultures of endothelial cells derived from microvasculature of rat brain, epididymal fat pad and from aorta

1 reference

7 January 2021

Active apical secretory efflux of the HIV protease inhibitors saquinavir and ritonavir in Caco-2 cell monolayers

1 reference

7 January 2021

The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors

1 reference

7 January 2021

In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors

1 reference

7 January 2021

Zidovudine transport in the rabbit brain during intravenous and intracerebroventricular infusion.

1 reference

7 January 2021

Determination of the pKa and pH-solubility behavior of an ionizable cyclic carbamate, (S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4- (trifluoromethyl)-2H-3,1-benzoxazin-2-one (DMP 266)

1 reference

7 January 2021

Preformulation studies of a novel HIV protease inhibitor, AG1343.

1 reference

7 January 2021

1 reference

7 January 2021

Microdialysis studies of the distribution of stavudine into the central nervous system in the freely-moving rat.

1 reference

7 January 2021

Restricted transport of 3'-azido-3'-deoxythymidine and dideoxynucleosides through the blood-brain barrier

1 reference

7 January 2021

Plasma and cerebrospinal fluid pharmacokinetics of 3'-azido-3'-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases

1 reference

7 January 2021

Brain and cerebrospinal fluid uptake of zidovudine (AZT) in rats after intravenous injection

1 reference

7 January 2021

Identifiers

DOI

10.1021/JS990174I

1 reference

29 July 2017

1 reference